Evidence map›Paper›PMID 37578593›Full record

ArticleInternational journal of hematology2023

Aortitis after administration of pegfilgrastim to a healthy donor for peripheral blood stem cell collection.

Yu Uemura, Kumi Oshima, Aika Fuseya, Akane Hosokai, Ayaka Ohashi, Masatoshi Kanno, Ayako Arai

Open access · hybridAbstract readCase Reports
In one paragraph

Article in International journal of hematology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yu UemuraDepartment of Hematology and Oncology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-Ku, Kawasaki, 216-8511, Japan.
Kumi OshimaDepartment of Hematology and Oncology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-Ku, Kawasaki, 216-8511, Japan.
Aika FuseyaDepartment of Hematology and Oncology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-Ku, Kawasaki, 216-8511, Japan.
Akane HosokaiDepartment of Hematology and Oncology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-Ku, Kawasaki, 216-8511, Japan.
Ayaka OhashiDepartment of Immunology and Parasitology, St. Marianna University School of Medicine, Kawasaki, Japan.
Masatoshi KannoDepartment of Hematology and Oncology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-Ku, Kawasaki, 216-8511, Japan.
Ayako AraiDepartment of Hematology and Oncology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-Ku, Kawasaki, 216-8511, Japan. ara.hema@marianna-u.ac.jp.ORCID http://orcid.org/0000-0002-8275-5372
St. Marianna University School of Medicine · JP

Funding

Japanese Agency for Medical Research and Development (AMED) 22ek0109612h0001
6 · The paper itself

Abstract

A 45-year-old man who was a sibling donor for allogeneic peripheral blood stem cell transplantation (allo-PBSCT) was administered 7.2 mg of pegfilgrastim for stem cell collection. Peripheral blood stem cells were collected 4 days after administration of pegfilgrastim (Day 4) and 4.32 × 10

Indexed as

AortitisHematopoietic Stem Cell TransplantationPeripheral Blood Stem CellsFilgrastimGranulocyte Colony-Stimulating FactorHumansMaleMiddle AgedPolyethylene GlycolsFilgrastimGranulocyte Colony-Stimulating FactorpegfilgrastimPolyethylene GlycolsAllogeneic peripheral blood stem cell transplantationAortitisDonorPegfilgrastim

Identifiers

PMID37578593
PMCPMC10673976
OpenAlexW4385798273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.